You are here

Article Text

Article menu

See original article:

Download PDFPDF

Erratum
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
  1. Frances M. Walocko1,
  2. Benjamin Y. Scheier2,
  3. Paul W. Harms3,4,
  4. Leslie A. Fecher2 and
  5. Christopher D. Lao2,e
  1. Aff1 0000000086837370grid.214458.eUniversity of Michigan Medical School Ann Arbor MI USA
  2. Aff2 0000000086837370grid.214458.eDivision of Hematology/Oncology, Department of Internal MedicineUniversity of Michigan C451 Med Inn, 1500 East Medical Center Drive 48109 Ann Arbor MI USA
  3. Aff3 0000000086837370grid.214458.eDepartment of PathologyUniversity of Michigan Ann Arbor MI USA
  4. Aff4 0000000086837370grid.214458.eDepartment of DermatologyUniversity of Michigan Ann Arbor MI USA
  1. ↵e clao{at}med.umich.edu

  • The online version of the original article can be found under doi:10.1186/s40425-016-0186-1.

https://doi.org/10.1186/s40425-017-0221-x

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Erratum

    Following publication of this article [1], it was noticed that the Clinical Trial Number in the last paragraph of the conclusions section was incorrectly listed as NCT02155647. The correct Clinical Trials Number is NCT02488759.

    Reference

    1. 1.↵
      2. Walocko FM ,
      3. Scheier BY ,
      4. Harms PW ,
      5. Fecher LA ,
      6. Lao CD
      . Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer. 2016;4:79 doi:10.1186/s40425-016-0186-1 pmcid:5109712
      OpenUrlAbstract/FREE Full Text